NI-1701 administration to tumor-bearing mice was shown to modify the tumor microenvironment by promoting the infiltration of immune cells, including M1-polarized inflammatory macrophages, NK cells, and CD11b−/+CD11c+ DCs, all known for their anti-tumorigenic functions [40–42]. Here, ITGAM is linked to neoplasm.